ADHD-ADD

News & Headlines

Advertisement

WEEKLY NEWSLETTER

Health's Top Stories
Get a weekly look at the most popular stories on Health.com.

Study Links ADHD Stimulants to Rare, Unexplained Deaths in Children

June 15, 2009

ritalin-adhd-deaths
By Amanda MacMillan

MONDAY, June 15, 2009 (Health.com) — After years of speculation and rare case reports, a study suggests that stimulant medication—mostly used to treat attention deficit hyperactivity disorder (ADHD)—may have played a role in a handful of cases of sudden, unexplained death in children and adolescents.

The study authors stress, however, that parents and doctors should not refrain from treating children with ADHD just because of these results.

“The association is significant in that it’s real, but that doesn’t mean it’s not a very low risk,” says lead author Madelyn S. Gould, PhD, a professor of psychiatry and public health at Columbia University, in New York. “There probably does need to be more careful monitoring, but the bottom line is that parents should not take their children off stimulant medication they’re currently on and should not be scared to have their child go on a stimulant if that’s what they and their doctors decide is the best thing for their child.”

The study, published this week in the American Journal of Psychiatry, is the first to suggest that the stimulants may pose a risk—albeit remote—in children without underlying heart problems. About 2.5 million children in the United States take such medications.

Next page: Stimulants linked to 1.8% of unexplained deaths



Most Popular Stories From Health.com:
 

Comments (1)

The following content represents the opinions of Health.com users. It is not editorially reviewed for medical or factual accuracy. It does not constitute medical advice. See your doctor for medical advice.
  • bridesmaiddresses

    You had better know about these things afore you start hunting for the wedding bridesmaid dresses, because not all styles of dress fit everyone.

Post a Comment

The rules: Keep it clean and stay on the subject or we may delete your comment.

Your email address is not published or shared. Required fields are marked with an asterisk (*)

*
*
 


We require all participants in interactive areas to accept the terms of the Time Inc. subscriber agreement. Please read the agreement before making comments. When you click on the button above to submit your comments, you are indicating your acceptance of and are agreeing to adhere to the terms of the subscriber agreement.
Text Size: Decrease Increase

WEEKLY NEWSLETTER

Health's Top Stories
Get a weekly look at the most popular stories on Health.com.
Advertisement
Close
  • Social Web
  • E-mail
Site powered by WordPress.com VIP